Form 8-K - Current report:
SEC Accession No. 0001213900-25-016103
Filing Date
2025-02-21
Accepted
2025-02-21 16:15:08
Documents
17
Period of Report
2025-02-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0231758-8k_180life.htm   iXBRL 8-K 64442
2 EXECUTIVE CONSULTING AGREEMENT ENTERED INTO ON FEBRUARY 15, 2025 AND EFFECTIVE J ea023175801ex10-1_180life.htm EX-10.1 114495
3 EXECUTIVE CONSULTING AGREEMENT DATED FEBRUARY 21, 2025, BY AND BETWEEN 180 LIFE ea023175801ex10-2_180life.htm EX-10.2 117758
4 FORM OF NOTICE OF RESTRICTED STOCK GRANT AND RESTRICTED STOCK GRANT AGREEMENT (F ea023175801ex10-3_180life.htm EX-10.3 58572
  Complete submission text file 0001213900-25-016103.txt   642960

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE atnf-20250215.xsd EX-101.SCH 3787
6 XBRL DEFINITION FILE atnf-20250215_def.xml EX-101.DEF 26629
7 XBRL LABEL FILE atnf-20250215_lab.xml EX-101.LAB 36680
8 XBRL PRESENTATION FILE atnf-20250215_pre.xml EX-101.PRE 25253
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0231758-8k_180life_htm.xml XML 5806
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 25652071
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)